JDD coverage and what to read next
JDD has published an increasing number of articles that examine the connections between GLP-1 therapies and skin health. As GLP-1 receptor agonists gain wider use for metabolic disease and weight management, dermatologists, primary care clinicians, researchers, and patients are seeking clear information about possible cutaneous effects, rare adverse events, and potential therapeutic interactions.
Read some of the articles below and more from the link for a concise evidence overview, real-world cases, and practical guidance for patient counseling and monitoring.
Natural Weight Loss or “Ozempic Face”: Demystifying A Social Media Phenomenon
Blog write-up assisted by AI
